Founder & CEO
We are an interdisciplinary team of thinkers and doers working together to create better medicines
Founder & CEO
Chief Financial Officer
Executive Vice President, Drug Discovery
Vice President, Human Resources
Chief Medical Officer Consultant
Director
Director
Director
Board Observer
Pro-Vice Chancellor for Innovation and Professor of Translational Medicine, Oxford University.
Corporate Vice President and General Manager Cloud Enterprise and Artificial Intelligence Solutions Group Intel Corporation.
Director, Vancouver Prostate Centre, and Distinguished Professor and Head, Department of Urologic Sciences, University of British Columbia.
Dean, Faculty of Medicine and Vice-President, Health, University of British Columbia.
HHMI Investigator, Distinguished Professor of Molecular & Cell Biology and Chemistry, University of California at Berkeley.
Scientific Vice President; Head, Induced Proximity Platform; Amgen, Inc.
Chair and Professor, Biochemistry and Molecular Biotechnology, Director, Institute for Drug Resistance, and Gladys Martin Smith Chair in Oncology, University of Massachusetts …
Director, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen.
Medical Oncologist, Independent Consultant.
Business Development Advisor
Abhishek Mukhopadhyay, Ph.D.
Allan Mah, Ph.D.
Ankoor Patel, Ph.D.
Benuelle Cabiara
Bronwyn Lyons, Ph.D.
Camille Fortinez, Ph.D.
Carman Lau
Charles Leung, Ph.D.
Christophe Sanchez
Dushyant Jahagirdar, Ph.D.
Ellen Gates
Emily Wight
George Gu
Johan Israelian, Ph.D.
Karen Luk
Karoline Leopold, Ph.D.
Katherine Rhodes
Kriti Singh, Ph.D.
Lee Freiburger, Ph.D.
Najeeb Malik
Natasha Broderick
Ravi Munuganti, Ph.D.
Xing Zhu
Yuan Gui